Levofloxacin plus aminoglycoside superior to ciprofloxacin after prostate biopsy
the ONA take:
This study investigated the potential benefit of oral fluoroquinolone prophylaxis in patients undergoing transrectal ultrasound-guided (TUG) prostate biopsy.
The researchers compared two prophylactic antibiotic regimens: one dose of ciprofloxacin 500 mg combined with an aminoglycoside (AG) or one dose of levofloxacin 750 mg combined with an AG.
The ciprofloxacin group involved 535 biopsies, and the levofloxacin 654 biopsies. Total infection rate was 3.18% in the ciprofloxacin group and 2.14% in the levofloxacin group.
The rate of mild infection was 0.75% in the ciprofloxacin group and 1.22% in the levofloxacin group; however, the rate of severe infection was higher in the ciprofloxacin group compared with the levofloxacin group (2.43% vs 0.92%, respectively).
Use of a single dose of fluoroquinolone augmented with an AG is optimal prophylaxis to reduce infectious complications in patients undergoing prostate biopsy.
The researchers found that 750 mg levofloxacin is more effective than 500 mg ciprofloxacin in reducing severe infections in these patients.
Use of single dose of fluoroquinoloneis optimal prophylaxis to reduce infectious complications in patients undergoing prostate biopsy.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|